Dockendorff Charles J 4

What Happened

• Charles J. Dockendorff, a director of Hologic, was awarded 3,190 restricted stock units (RSUs) on 2026-02-26. The grant is an equity compensation award (no purchase price or cash exchanged), so no per-share price or immediate dollar value is reported.

Key Details

• Transaction date: 2026-02-26; Form 4 filed 2026-03-02 reporting the grant.
• Transaction type: Award/Grant (code A) — RSUs (no exercise price).
• Number of RSUs granted: 3,190.
• Vesting/settlement: Footnote F1 — RSUs vest on the date of the 2027 Annual Meeting of Stockholders; F2 — each RSU settles one-for-one into a share of common stock when vested.
• Shares owned after the transaction: not specified in the information provided.
• Filing timeliness: Form 4 was filed on 2026-03-02 to report the 2026-02-26 grant; the filing itself does not indicate a late-filing code.

Context

• RSU grants to directors are common as part of compensation and are not the same as an open-market purchase or sale — they reflect pay rather than a direct market bet by the insider. The award will convert to common shares when the RSUs vest (on the 2027 Annual Meeting date), at which point any subsequent sale would be reported separately.